<SEC-DOCUMENT>0001213900-25-014301.txt : 20250214
<SEC-HEADER>0001213900-25-014301.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214163013
ACCESSION NUMBER:		0001213900-25-014301
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250214
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SCHULTES KRISTIN B
		CENTRAL INDEX KEY:			0002046195
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42524
		FILM NUMBER:		25629622

	MAIL ADDRESS:	
		STREET 1:		C/O ACUREN CORPORATION
		STREET 2:		14434 MEDICAL COMPLEX DRIVE; SUITE 100
		CITY:			TOMBALL
		STATE:			TX
		ZIP:			77377

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACUREN CORP
		CENTRAL INDEX KEY:			0002032966
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		14434 MEDICAL COMPLEX DRIVE
		STREET 2:		#100
		CITY:			TOMBALL
		STATE:			TX
		ZIP:			77377
		BUSINESS PHONE:		800-218-7450

	MAIL ADDRESS:	
		STREET 1:		14434 MEDICAL COMPLEX DRIVE
		STREET 2:		#100
		CITY:			TOMBALL
		STATE:			TX
		ZIP:			77377
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2025-02-14</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0002032966</issuerCik>
        <issuerName>ACUREN CORP</issuerName>
        <issuerTradingSymbol>TIC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002046195</rptOwnerCik>
            <rptOwnerName>SCHULTES KRISTIN B</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ACUREN CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>14434 MEDICAL COMPLEX DRIVE, SUITE 100</rptOwnerStreet2>
            <rptOwnerCity>TOMBALL</rptOwnerCity>
            <rptOwnerState>TX</rptOwnerState>
            <rptOwnerZipCode>77377</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>30000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Performance Based Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F4"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F3"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>30000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (December 3, 2024).</footnote>
        <footnote id="F2">Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.</footnote>
        <footnote id="F3">Subject to the volume weighted average price (&quot;VWAP&quot;) of the Issuer's Common Stock reaching $20.00 over a ten (10) consecutive trading day period at any time during the period commencing on the date on which the Common Stock is listed on the New York Stock Exchange and ending on December 3, 2029 (the &quot;VWAP Achievement Period&quot;), these performance based restricted stock units shall vest on the later of (x) December 3, 2025 and the calendar day following the last day of the VWAP Achievement Period.</footnote>
        <footnote id="F4">Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.</footnote>
    </footnotes>

    <remarks>See Exhibit 24.1 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Fiona Sutherland, Attorney in Fact</signatureName>
        <signatureDate>2025-02-14</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ea022992501ex24-1_acuren.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in; text-align: right"><B>Exhibit 24.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0in; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0in; text-align: center"><B><U>POWER OF ATTORNEY</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0in; margin: 0pt 0in">Know all by these presents, that the undersigned hereby constitutes
Fiona Sutherland, the undersigned&rsquo;s true and lawful attorney-in-fact to:</P>

<P STYLE="text-indent: 0in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: left">execute for and on behalf of the undersigned, in any and
all capacities, Form ID, including other documents necessary to obtain EDGAR codes and passwords enabling the undersigned to make electronic
filings with the United States Securities and Exchange Commission (the &ldquo;Commission&rdquo;), Form 144 in accordance with Rule 144
under and Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder as well
as a Schedule 13D or Schedule 13G and any amendments thereto (collectively, the &ldquo;Required Filings&rdquo;);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: left">do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any such Required Filings, complete and execute any amendment
or amendments thereto, and timely file such form with the Commission and any stock exchange or similar authority;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: left">seek or obtain, as the undersigned&rsquo;s representative and on
the undersigned&rsquo;s behalf, information regarding transactions in the securities of Acuren Corporation (the &ldquo;Company&rdquo;) from any
third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person
to release any such information to such attorney-in-fact and approves and ratifies any such release of information; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: left">take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact&rsquo;s discretion.</TD>
</TR></TABLE>

<P STYLE="text-indent: 0in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0in; margin: 0pt 0in">The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact&rsquo;s
substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the undersigned&rsquo;s responsibilities to comply with Section 16 of the Securities Exchange
Act of 1934, as amended.</P>

<P STYLE="text-indent: 0in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0in; margin: 0pt 0in">This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Form 144, Forms 3, 4, and 5 and Schedule 13D or Schedule 13G with respect to the undersigned&rsquo;s
holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.</P>

<P STYLE="text-indent: 0in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: left; text-indent: 0in">IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 19<SUP>th</SUP> day of November, 2024.</P>

<P STYLE="text-indent: 0in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%"></TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: left">/s/ Kristin B. Schultes</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Name: Kristin B. Schultes</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-indent: 0in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0in"></P>

<P STYLE="text-indent: 0in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
